Evidence map›Paper›PMID 40471325›Full record

ArticleArchives of dermatological research2025

Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients.

Alaa Sh Abdulbari, Noor M Ali, Ahmed Rahmah Abu-Raghif, Nadheer A Matloob, Hayder Ridha-Salman

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alaa Sh AbdulbariDepartment of Chemistry, College of Applied Sciences, University of Technology- Iraq, Baghdad, Iraq.
Noor M AliDepartment of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq.
Ahmed Rahmah Abu-RaghifDepartment of Pharmacology, College of Medicine, AL-Nahrain University, Baghdad, Iraq.ORCID http://orcid.org/0000-0003-4514-3892
Nadheer A MatloobSection of Dermatology & Venereology, College of Medicine, AL-Nahrain University, Baghdad, Iraq.
Hayder Ridha-SalmanCollege of Pharmacy, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq. hayder80.ridha@gmail.com.ORCID http://orcid.org/0000-0003-1594-4883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acne vulgaris (AV) is a persistent inflammatory skin disease that affects the pilosebaceous units. Oral azithromycin has shown significant effectiveness in treating AV, attributed to its robust anti-inflammatory and antimicrobial properties. This study aimed to evaluate the efficacy of azithromycin in patients with moderate-to-severe AV, with a focus on its influence on sebum composition and specific biomarkers, including pyridoxine (B6), biotin (B7), cobalamin (B12) (measured by HPLC), and homocysteine (measured by ELISA). A case-control study was conducted at the dermatology department of Al-Imamain-Alkadhimain Medical City, Baghdad. The study included thirty patients aged 15-35 years with moderate-to-severe AV, and thirty healthy individuals of the same age and sex served as a control group. Patients received 500 mg of azithromycin on alternate days for 12 weeks. Laboratory and clinical parameters were assessed at baseline and compared to the control group, then re-evaluated after treatment. The findings indicated a significant decrease in serum levels of folic acid, B7, and B6 at both 6 and 12 weeks post-treatment (p < 0.05). Serum homocysteine levels increased slightly over time, but this change was not statistically significant (p > 0.05). No significant difference in serum B12 levels was observed at 6 weeks (p > 0.05); however, a significant increase was noted at 12 weeks (p < 0.05). Clinical score, skin moisture, and sebum squalene (Sebum-SQ) content improved significantly post-treatment (p < 0.05), while sebum cholesterol (Sebum-Chol.) levels showed significant change only at 12 weeks (p < 0.05). The finding supports the efficacy of azithromycin in managing inflammatory acne and modulating sebum composition and specific biomarkers. However, the relatively small sample size and absence of power analysis limit the generalizability of the results. Future studies with larger cohorts are recommended to validate these findings.

Indexed as

Acne VulgarisAnti-Bacterial AgentsAzithromycinSebumAdolescentAdultBiomarkersCase-Control StudiesFemaleHomocysteineHumansMalePyridoxineSeverity of Illness IndexTreatment OutcomeVitamin B 12Anti-Bacterial AgentsAzithromycinBiomarkersHomocysteinePyridoxineVitamin B 12Vitamin B 6Acne vulgarisAzithromycinDermatological conditionsHomocysteineInflammatory diseasesSebumSebutapeVitamin B12Vitamin B7

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.